VF
TMO icon

Virtu Financial’s Thermo Fisher Scientific TMO Stock Holding History

Virtu Financial’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,421
Closed -$4.57M – 2233
2025
Q3 		$4.57M Buy
9,421
+6,087
+183% +$2.83M 0.26% 69
2025
Q2 		$1.35M Sell
3,334
-21,611
-87% -$9.04M 0.07% 255
2025
Q1 		$12.4M Buy
24,945
+12,990
+109% +$7.04M 0.68% 13
2024
Q4 		$6.22M Buy
11,955
+10,923
+1,058% +$6.01M 0.33% 37
2024
Q3 		$638K Buy
+1,032
New +$611K 0.04% 373
2024
Q1 		– Sell
-557
Closed -$295K – 2095
2023
Q4 		$295K Buy
+557
New +$270K 0.02% 609
2023
Q3 		– Sell
-7,556
Closed -$3.94M – 1906
2023
Q2 		$3.94M Buy
+7,556
New +$4.08M 0.3% 53
2022
Q4 		– Sell
-1,560
Closed -$791K – 2132
2022
Q3 		$791K Buy
+1,560
New +$873K 0.07% 249
2022
Q1 		– Sell
-3,862
Closed -$2.58M – 2032
2021
Q4 		$2.58M Buy
3,862
+798
+26% +$498K 0.26% 80
2021
Q3 		$1.75M Buy
+3,064
New +$1.68M 0.15% 114
2021
Q2 		– Sell
-632
Closed -$288K – 2074
2021
Q1 		$288K Buy
+632
New +$302K 0.02% 836
2019
Q1 		– Sell
-5,415
Closed -$1.21M – 1836
2018
Q4 		$1.21M Buy
+5,415
New +$1.27M 0.07% 229
2018
Q3 		– Sell
-2,844
Closed -$589K – 2190
2018
Q2 		$589K Sell
2,844
-624
-18% -$132K 0.04% 703
2018
Q1 		$716K Sell
3,468
-4,274
-55% -$897K 0.04% 513
2017
Q4 		$1.47M Sell
7,742
-9,668
-56% -$1.85M 0.08% 289
2017
Q3 		$3.29M Buy
+17,410
New +$3.15M 0.16% 74
2017
Q1 		– Sell
-3,804
Closed -$537K – 573
2016
Q4 		$537K Buy
+3,804
New +$561K 0.06% 238

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Virtu Financial's TMO Position: Q4 2025 in Review

Virtu Financial sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 9,421 shares — an estimated $4.57M sold.

Virtu Financial first reported a position in TMO in Q4 2016 and held it in 17 quarters. The position peaked at $12.4M in Q1 2025. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Virtu Financial reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 9,421 Thermo Fisher Scientific shares in Q4 2025, an estimated $4.57M.
  • Virtu Financial first reported a position in Thermo Fisher Scientific in Q4 2016 and held it in 17 quarters.
  • Virtu Financial's Thermo Fisher Scientific position peaked at $12.4M in Q1 2025.
  • 2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.